MiRNA Profiling of Cancer

Overview

Journal Curr Opin Genet Dev

Publisher Elsevier

Specialties Biology
Genetics

Date 2013 Mar 8

PMID 23465882

Citations 227

Authors

Gianpiero Di Leva

Carlo M Croce

Affiliations

Soon will be listed here.

Abstract

A steadily growing number of studies have shown that microRNAs have key roles in the regulation of cellular processes and that their dysregulation is essential to keep the malignant phenotype of cancer cells. The distorted and unique expression profile of microRNAs in different types and subsets of tumor coupled with their presence in biological fluids make of microRNAs an attractive source of sensitive biomarkers. Here, we will discuss how microRNA profiles are altered in cancer, highlighting their potential as sensitive biomarkers for cancer risk stratification, outcome prediction and classification of histological subtypes. We will also evaluate the current knowledge on the use of microRNAs as circulating biomarkers, hoping that further studies will lead to the application of microRNA signature in prognostic and predictive markers that can improve patient health.

Citing Articles

MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring.

Kepsha M, Timofeeva A, Chernyshev V, Silachev D, Mezhevitinova E, Sukhikh G Int J Mol Sci. 2025; 25(24.

PMID: 39769036 PMC: 11678179. DOI: 10.3390/ijms252413271.

MiRNA Expression in Long-Distance Runners with Musculoskeletal Pain: Implications for Pain Pathophysiology.

Tumolo M, Bodini A, Bagordo F, Leo C, Mincarone P, De Matteis E Biomedicines. 2024; 12(11).

PMID: 39595060 PMC: 11591860. DOI: 10.3390/biomedicines12112494.

miR-4486 inhibits colorectal cancer proliferation via targeting MAP2K4 to inhibit the activation of the p38MAPK/JNK signaling.

Wang W, Chen L, Xu F, Chen R, Li Q, Zou L Heliyon. 2024; 10(21):e38926.

PMID: 39512455 PMC: 11539255. DOI: 10.1016/j.heliyon.2024.e38926.

Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment.

Sebutsoe X, Tsotetsi N, Jantjies Z, Raphela-Choma P, Choene M, Motadi L Onco Targets Ther. 2024; 17:785-801.

PMID: 39345275 PMC: 11439348. DOI: 10.2147/OTT.S475132.

miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses.

Toropko M, Chuvpilo S, Karabelsky A Pharmaceutics. 2024; 16(8).

PMID: 39204331 PMC: 11360794. DOI: 10.3390/pharmaceutics16080986.

References

He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S . The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005; 102(52):19075-80. PMC: 1323209. DOI: 10.1073/pnas.0509603102. View

Ciafre S, Galardi S, Mangiola A, Ferracin M, Liu C, Sabatino G . Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005; 334(4):1351-8. DOI: 10.1016/j.bbrc.2005.07.030. View

He L, Thomson J, Hemann M, Hernando-Monge E, Mu D, Goodson S . A microRNA polycistron as a potential human oncogene. Nature. 2005; 435(7043):828-33. PMC: 4599349. DOI: 10.1038/nature03552. View

Shah M, Calin G . MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med. 2011; 3(8):56. PMC: 3238182. DOI: 10.1186/gm272. View

de Leeuw R, Davies J, Rosenwald A, Bebb G, Gascoyne R, Dyer M . Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet. 2004; 13(17):1827-37. DOI: 10.1093/hmg/ddh195. View

Chen R, Bemis L, Amato C, Myint H, Tran H, Birks D . Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood. 2008; 112(3):822-9. PMC: 2481543. DOI: 10.1182/blood-2008-03-142182. View

Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G . The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601. DOI: 10.1038/ncb1722. View

Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M . MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg. 2008; 12(12):2171-6. PMC: 4055565. DOI: 10.1007/s11605-008-0584-x. View

Blenkiron C, Goldstein L, Thorne N, Spiteri I, Chin S, Dunning M . MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007; 8(10):R214. PMC: 2246288. DOI: 10.1186/gb-2007-8-10-r214. View

10.

Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N . Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A. 2006; 103(18):7024-9. PMC: 1459012. DOI: 10.1073/pnas.0602266103. View

11.

Giannini E, Erroi V, Trevisani F . Effectiveness of α-fetoprotein for hepatocellular carcinoma surveillance: the return of the living-dead?. Expert Rev Gastroenterol Hepatol. 2012; 6(4):441-4. DOI: 10.1586/egh.12.30. View

12.

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

13.

Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S . MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med. 2009; 361(15):1437-47. PMC: 2786938. DOI: 10.1056/NEJMoa0901282. View

14.

Eis P, Tam W, Sun L, Chadburn A, Li Z, Gomez M . Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005; 102(10):3627-32. PMC: 552785. DOI: 10.1073/pnas.0500613102. View

15.

Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S . MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16):7065-70. DOI: 10.1158/0008-5472.CAN-05-1783. View

16.

Kim V, Han J, Siomi M . Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009; 10(2):126-39. DOI: 10.1038/nrm2632. View

17.

Volinia S, Galasso M, Sana M, Wise T, Palatini J, Huebner K . Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci U S A. 2012; 109(8):3024-9. PMC: 3286983. DOI: 10.1073/pnas.1200010109. View

18.

Heneghan H, Miller N, Lowery A, Sweeney K, Newell J, Kerin M . Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg. 2010; 251(3):499-505. DOI: 10.1097/SLA.0b013e3181cc939f. View

19.

Duffy M . Serum tumor markers in breast cancer: are they of clinical value?. Clin Chem. 2006; 52(3):345-51. DOI: 10.1373/clinchem.2005.059832. View

20.

Bockmeyer C, Christgen M, Muller M, Fischer S, Ahrens P, Langer F . MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Breast Cancer Res Treat. 2011; 130(3):735-45. DOI: 10.1007/s10549-010-1303-3. View